XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.21.2

Accrued Liabilities | 9 Months Ended
--- | ---
Sep. 30, 2021
Payables and Accruals [Abstract] |
Accrued Liabilities | ACCRUED LIABILITIES
(in millions) | September 30, 2021 |  |  | December 31, 2020
Employee compensation and benefits | $ | 54.0 |  |  |  | $ | 48.9 |
Legal accrual | 48.0 |  |  |  | — |
Accrued taxes payable | 17.3 |  |  |  | 4.3 |
Refunds payable and reserves | 8.9 |  |  |  | 9.3 |
Short-term contingent consideration | 3.3 |  |  |  | 3.4 |
Accrued royalties | 5.0 |  |  |  | 3.8 |
Purchase commitment | 5.2 |  |  |  | — |
Other accrued liabilities | 21.5 |  |  |  | 9.4 |
Total accrued liabilities | $ | 163.2 |  |  |  | $ | 79.1 |
During the quarter ended September 30, 2021, the Company accrued $48.0 million for a potential settlement of the qui tam lawsuit against Crescendo Bioscience, Inc. and the Company. Refer to Note 13 for additional information.

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration